Genmab — Maj 2022
-
Peter12 22.18. Hvis salgstallet var -2,4% er det megagodt! Der var 23 arbejdsdage i marts og kun 21 i april. Nu har jeg ikke de eksakte tal, men det kunne være rart. Umiddelbart tyder det på en dag-dag stigning (arbejdsdage) på noget der ved hurtig hovedregning ligner et plus på 6,9%
-
Det må man sige. Se dagsgrafen og sammenlign med tidspunktet for Darvins indlæg. Den sidder lige i skabet.
-
Aktier/middag: C25 mod største stigning nogensinde efter to lukkedage
https://www.proinvestor.com/investornyt/830896/aktier-middag-c25-mod-storste-stigning-nogensinde-efter-to-lukkedage -
God morgen.
-
-
Move over Humira, it's the cancer antibodies' turn at the top https://www.evaluate.com/vantage/articles/insights/other-data-snippets/move-over-humira-its-cancer-antibodies-turn-top
-
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: results from the innovaTV 206 study https://onlinelibrary.wiley.com/doi/10.1111/cas.15443
-
Mitigation and management strategies for ocular events associated with tisotumab vedotin https://www.gynecologiconcology-online.net/article/S0090-8258(22)00120-2/fulltext
-
https://meetings.asco.org/abstracts-presentations/206862 Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205.
-
CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) https://library.ehaweb.org/eha/2022/eha2022-congress/357065/carmelo.carlo-stella.camidanlumab.tesirine.updated.efficacy.and.safety.in.an.html
-
Amivantamab and lazertinib in patients with EGFR-mutant non–small cell lung (NSCLC) after progression on osimertinib and platinum-based chemotherapy: Updated results from CHRYSALIS-2. https://meetings.asco.org/abstracts-presentations/208278
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind